ibrutinib,rituximab
abbvie,janssen
[' ibru', 'hodgkin', 'mantle,(-dismantle)', 'ritux', 'lymphoma']
and we start the plenary session of #ash22 with the results of the trial: what do you think? still room for asct in patients with mcl in the era of ibrutinib? 
MD @ClevelandClinic @unitorvergata | Lymphoma survivor#Resilient | MDS/AML/APL/Bone marrow failure syndromes| Member @TheEBMT_Trainee | Opinions are my own